Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

US10052312B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Alexandros Vakalopoulos · Hilden, DE
• Markus Follmann
• Ingo Hartung · Berlin, DE
• Philipp Buchgraber · Leverkusen, DE
• Rolf Jautelat · Haan, DE
• Jorma HAßFELD · Mülheim an der Ruhr, DE
• Niels Lindner · Wuppertal, DE
• Alexey GROMOV · Erkrath, DE
• Frank Wunder · Wuppertal, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Volkhart Min-Jian Li · Velbert, DE
• Eva Maria Becker-Pelster · Wuppertal, DE
• Andreas Knorr · Erkrath, DE

Key dates

• Filing date: Mar 2, 2017
• Grant date: Aug 21, 2018
• Expiry date: Mar 2, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.